Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment
Phase 4
- Conditions
- Abortion, SpontaneousAbortion, Induced
- Registration Number
- NCT00256009
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
A randomize trial: expectation or evacuatio uteri for the treatment after late abortion
- Detailed Description
A randomize trial adressing 200 women consecutively recruited from clinical practice at Rigshospitalet.Expectation: administration of 800 microgram Cytotec half an hour after delivery. Surgery: Evacuation of the uterus
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
abortion at gestational age (ultrasound) 14+0 - 20+0
Exclusion Criteria
Allergy to cytotec
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Side-effect Complication
- Secondary Outcome Measures
Name Time Method Quality of life
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Cytotec's efficacy in post-abortion uterine evacuation?
How does uterine evacuation compare to conservative management in late spontaneous abortion outcomes?
Are there biomarkers that predict response to Cytotec in post-abortion care?
What adverse events are associated with Cytotec use after late induced or spontaneous abortion?
What alternative drug regimens or surgical techniques are used for uterine evacuation in post-abortion care?